VC-backed Pliant Therapeutics goes public
South San Francisco-based Pliant Therapeutics Inc, a developer of therapies that treat fibrosis, has raised $144 million for its IPO after it priced its 9 million shares at $16 per share.
South San Francisco-based Pliant Therapeutics Inc, a developer of therapies that treat fibrosis, has raised $144 million for its IPO after it priced its 9 million shares at $16 per share.
Copyright PEI Media
Not for publication, email or dissemination